Paul Johnson, CEO and co-founder of Lemonaid Health, a direct to consumer telehealth company discusses the critical role telehealth is playing during COVID-19 and how the sudden surge in remote appointments has created another infrastructure challenge for providers and health systems that are causing patients to spend hours in virtual waiting rooms due to unprecedented demand. Direct to consumer telehealth gives patients an alternative option for immediate treatment of non-acute conditions. To date, the company has treated more than a million patients online via its own medical team, for a variety of medical conditions ranging fromerectile dysfunction to sinus infections to depression and anxiety.
Paul is the co-founder and CEO of Lemonaid Health. He moved from the UK to the US in 2014. In the UK Paul’s entrepreneurial career started aged 17 where I was a runner up in a Daily Mail sponsored entrepreneur of the year competition and founded his first company ran from the garage of his family home. Later Paul founded and ran the UK’s largest online pet retailer and became Head of Online for the second largest drugstore chain. Paul continues to advise McKinsey & Company and others on e-commerce, innovation and business strategy. In the UK Paul was an advisor to the Government on Entrepreneurism and Enterprise.